Dr. Ibrahim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
New Hampshire Ave
Silver Spring, MD 20903Phone+1 703-624-5023- Is this information wrong?
Education & Training
- Dow University of Health SciencesClass of 1988
Publications & Presentations
PubMed
- 122 citationsFDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin‐Containing ChemotherapyDaniel L. Suzman, Sundeep Agrawal, Yang Min Ning, V. Ellen Maher, Laura L. Fernandes, Stella W. Karuri, Shenghui Tang, Rajeshwari Sridhara, Jason Schroeder, Kirsten B....> ;The Oncologist. 2019 Apr 1
- 36 citationsU.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma.Harpreet Singh, Michael Brave, Julia A. Beaver, Joyce Cheng, Shenghui Tang, Eias Zahalka, Todd R. Palmby, Rajesh Venugopal, Pengfei Song, Qi Liu, Chao Liu, Jingyu Yu, ...> ;Clinical Cancer Research. 2017 Jan 15
- 67 citationsFDA Approval Summary: Nivolumab in Advanced Renal Cell Carcinoma After Anti-Angiogenic Therapy and Exploratory Predictive Biomarker AnalysisJames Xu, V. Ellen Maher, Lijun Zhang, Shenghui Tang, Rajeshwari Sridhara, Amna Ibrahim, Geoffrey Kim, Richard Pazdur> ;The Oncologist. 2017 Mar 1
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: